CHRN Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 30.02
- P/S (TTM)
- 39.26
- EV/EBITDA
- 123.39
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- -39.4%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 1.03
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About ChronoScale Corporation
Company profileChronoScale Corporation (Ticker: CHRN) is an innovative biotechnology firm committed to advancing healthcare through the development and commercialization of groundbreaking therapeutics targeted at unmet medical needs. With a strong pipeline bolstered by strategic partnerships and a focus on leveraging cutting-edge technology, CHRN is poised to make significant contributions to patient care and drive advancements in the industry. Its dedication to scientific rigor and excellence positions the company to capitalize on emerging opportunities within the fast-evolving healthcare sector,…
Classification
- Sector
- Technology
- Industry
- Information Technology Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 3811 TURTLE CREEK BLVD., DALLAS, TX
- Fiscal year end
- May
- Latest quarter
- May 31, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer